PHARMACYTE BIOTECH, INC. Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions
PHARMACYTE BIOTECH, INC. (PMCB) reported Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions of 14.50% for the 12-month period ending 2013-04-30, per its 10-K filed 2013-07-29.
Discontinued › Notes › Equity
us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions · last filed 2013-07-29
- PHARMACYTE BIOTECH, INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for fiscal 2013 was 14.50%.
| Period end | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 12 month |
|---|---|
| 2013-04-30 | 14.50% 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |